Award
NIH Reporter #5R44EY031202-06
A Model for Predicting 2-Year Risk of Incident Late Age-related Macular Degeneration
Recipient
IHEALTHSCREEN, INC.
Award Amount
$698,032.00
Ceiling
$698,032.00
Awarded
September 10, 2026
Identifier
5R44EY031202-06
This NIH-funded project supports the development and clinical validation of iPredict-AMD, an AI software designed to predict the 2-year risk of late age-related macular degeneration, aiming for FDA approval and commercialization.
Description
The project aims to validate an AI-based screening and prediction system, iPredict-AMD, for early diagnosis and risk assessment of age-related macular degeneration (AMD). It involves developing and validating AI software for screening and predicting late AMD, conducting prospective clinical trials for FDA approval and commercialization, addressing a market gap identified by NIH SBIR Phase II award.